LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio sat down with new member AB Enzymes, to find out about their highly customizable enzymes solutions

    15/12/2021
    INTERVIEW

    About Martin Klavs Nielsen

    Martin holds a Master of Science in Chemical Engineering (DTU) and an MBA (SIMI). He worked many years for IFF/Dupont/Danisco in various positions (Application Director, Sales Director, Executive VP of Enablers Division etc.) He started 2012 in Associated British Food as CEO for Ohly and then in 2014 became CEO of AB Enzymes. Martin is currently working from AB Enzymes headquarter in Darmstadt Germany

    Interview with... Martin Klavs Nielsen, CEO at AB Enzymes

    1) What inspired AB Enzymes to join EuropaBio? Companies like AB Enzymes who work within the bio/ fermentation area will be an important part in improving everyday life for everyone in a sustainable manner. By becoming a member of EuropaBio, we aim at taking part of the European biotech effort to promote the benefits of the biotech industry, the potential contribution of Biotech in working towards a sustainable environment and contribute to the United Nations Sustainable Development Goals. We firmly believe that together, joined in this largest Biotech industry association, we can further explain and promote the benefits that our industry can bring in solving the challenges for mankind (feeding a growing world population and contributing to sustainable development while doing so) and thereby driving a positive impact to ensure a better life in a growing world.

    2) What are the policy areas which offer opportunities and potential challenges for enzymes in the EU?
    Especially in Biotech, technology is developing rapidly. Thus, the access to new state-of-the-art, efficient, accurate and safe tools and techniques is essential to EU research and development, in order to secure a thriving biotech industry in Europe. As other members, we consider that the current regulatory system is not fit for purpose and not future proof. Therefore, we would aim at joining forces in rethinking the regulatory approach to fermentation products in the EU, turning it into a science-based, transparent, and predictable regulatory environment, favourable for the Industrial biotech industry. Joining EuropaBio makes it possible for AB Enzyme to join forces with others and address legislators in EU with a strong voice.

    3) What are the priorities of your clients?
    The priorities of our customers are to be offered new types of enzymes which can help them improve their products within the food, feed and technical area. These improvements done by enzymes should be achieved in a cost-in-use efficient manner. Customers now also emphasise the need for sustainable solution(s) and understand what enzymes can offer in this respect.

    4) How does AB Enzymes want to position itself within the European biotech economy?
    At AB Enzymes, we are passionate about biotechnology and the potential to create added value, protect the environment and improve the quality of enzymes and related fermentation products sold to the food, feed and technical area across the world. We are committed to our various partners in Europe, and by working closely together with our customers and have a deep understanding of what they really want, we constantly seek to improve our products, find new applications, discover new molecules and increase value for our customers, through new and/or improved bespoke solutions aiming at a more sustainable future, achieving and guaranteeing long-term and lasting success.

    Interview with AB Enzymes


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    03/04/2026

    Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture


    Read more
    02/04/2026

    The EU Biotech Act II: A vital Act for biomanufacturing in Europe


    Read more
    31/03/2026

    Nestlé joins EuropaBio: Driving Innovation for Sustainable Food Systems


    Read more

    Important links

    • Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture
    • The EU Biotech Act II: A vital Act for biomanufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.